Caris Life Sciences (CAI) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	49.67M
Accounts receivable, net	727.18M
Deferred income taxes
Prepaid expenses and other current assets	83.85M
Total current assets	860.7M
Goodwill	2.58B
Intangible assets, net
Property and equipment, net	83.6M
Supplemental retirement savings plan assets
Accounts receivable, long-term	7.92M
Other long-term assets	24.23M
Total assets	3.91B
Current portion of long-term debt	53.97M
Accounts payable	55.02M
Accrued compensation and benefits	216.85M
Other accrued expenses and current liabilities	176.28M
Total current liabilities	502.1M
Long-term debt, net of current portion	1.34B
Supplemental retirement savings plan obligations, net of current portion
Deferred income taxes	262.12M
Other long-term liabilities	78.64M
Total liabilities	2.27B
Commitments and contingencies	0
Preferred stock $0.10 par value, 10,000 shares authorized, no shares issued	0
Common stock $0.10 par value, 80,000 shares authorized; 41,622 issued and 24,184 outstanding at June 30, 2015 and 41,441 issued and 23,500 outstanding at June 30, 2014	4.18M
Additional paid-in capital	560.31M
Retained earnings	1.7B
Accumulated other comprehensive loss	-41.93M
Treasury stock, at cost (17,438 and 17,941 shares, respectively)	-576.19M
Total CACI shareholders' equity	1.64B
Noncontrolling interest	135K
Total shareholders' equity	1.65B
Total liabilities and shareholders' equity	3.91B

Entities mentioned with CAI

View All Entities